Rare Diseases

The University of British Columbia’s Collaboration for Outcomes Research and Evaluation (CORE) group addresses the need for clinical and economic research, and education in pharmaceutical outcomes assessment. The CORE team is a multidisciplinary group of researchers with expertise in clinical pharmacy, pharmacoepidemiology, health economics, health services research, program evaluation and health promotion research.

CORE strives to provide evidence which will maximize the clinical, quality of life, and economic benefits of drug therapy, while minimizing associated risks. This is achieved through independent research and research collaborations with pharmaceutical and health outcomes researchers throughout North America and Europe.